AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Gblin M 750mcg/75mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Alkem Laboratories Ltd

Salt Composition

Methylcobalamin (750mcg) + Pregabalin (75mg)

Overview Gblin M 750mcg/75mg Tablet SR

Gablin-M 750mcg/75mg Extended-Release Tablets are a prescription medication for managing neuropathic pain. Its mechanism involves regulating calcium channel function within nerve cells, thus reducing pain signals. This medication also offers neuroprotective benefits, aiding in nerve fiber preservation and the repair of damaged neurons. Gablin-M 750mcg/75mg Extended-Release Tablets are administered orally, with or without food, ideally at bedtime for consistent blood levels. Maintain a regular dosing schedule as prescribed, adhering to your physician's instructions regarding dosage and duration, as this medication has addictive potential. If a dose is missed, take it immediately upon recollection. Complete the entire course of therapy, even if symptoms improve. Abrupt cessation should be avoided without consulting your doctor. Commonly reported side effects include nasal congestion, increased hunger, elevated mood, trembling, visual blurring, dry mouth, lightheadedness, and drowsiness. Avoid activities requiring concentration until the drug's effects are known. These side effects are typically mild and resolve over time. Weight gain is a potential consequence; counter this through regular exercise and a nutritious diet. Report any unusual mood or behavioral changes, new or worsening depression, or suicidal ideation to your doctor immediately. Disclose all other medications you are using, as interactions may reduce Gablin-M's effectiveness or alter its action. Inform your physician if you are pregnant, considering pregnancy, or breastfeeding.

Uses of Gblin M 750mcg/75mg Tablet SR

Managing neuropathic pain

Major Benefits of Gblin M 750mcg/75mg Tablet SR:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Gblin M 750mcg/75mg Sustained-Release tablet can be consumed with or without food, although consistent timing is recommended.

Common Side effects of Gblin M 750mcg/75mg Tablet SR:

  • Sleepiness
  • Dizziness
  • Nasopharyngitis (inflammation of the throat and nasal passages)
  • Increased appetite
  • Blurred vision
  • Constipation
  • Muscle cramp
  • Edema (swelling)
  • Erectile dysfunction
  • Weight gain
  • Balance disorder (loss of balance)
  • Lethargy
  • Vertigo
  • Vomiting
  • Headache
  • Confusion
  • Disorientation
  • Abnormality of voluntary movements

How to use Gblin M 750mcg/75mg Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Gblin M 750mcg/75mg Sustained-Release tablets can be consumed with or without food, although consistent daily timing is recommended.

How Gblin M 750mcg/75mg Tablet SR works:

Combipreg 750mcg/75mg Extended-Release Tablets contain methylcobalamin and pregabalin. Methylcobalamin, a vitamin B12 derivative, supports myelin sheath formation, protecting and repairing nerve cells. Pregabalin, an alpha-2-delta calcium channel ligand, reduces pain signals by modulating nerve cell calcium influx. This dual action provides relief from neuropathic pain stemming from nerve damage.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concomitant use of Gblin M 750mcg/75mg sustained-release tablets and alcohol may result in increased sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Gblin M 750mcg/75mg Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Gblin M 750mcg/75mg tablet is likely unsuitable for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Taking Gblin M 750mcg/75mg Extended-Release Tablets might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Gblin M 750mcg/75mg extended-release tablets cautiously. Dosage modification of Gblin M 750mcg/75mg extended-release tablets may be necessary. Physician consultation is advised.

LiverLiverSAFE IF PRESCRIBED

The use of Gblin M 750mcg/75mg Tablet SR in patients with liver disease appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary, though data are limited. Physician consultation is recommended.

What if you forget to take Gblin M 750mcg/75mg Tablet SR :

Should you forget a dose of Gblin M 750mcg/75mg Extended-Release Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Gblin M 750mcg/75mg Tablet SR

LabelValue
Addictive None.
Medication Classification Nervous System

FAQs on Gblin M 750mcg/75mg Tablet SR

Each Gblin M 750mcg/75mg sustained-release tablet contains pregabalin and methylcobalamin. This dual-action formulation treats neuropathic pain by modulating overactive or injured nerves within the central nervous system, reducing pain perception. Simultaneously, it promotes the repair of damaged nerves.
Discontinuing Gblin M 750mcg/75mg Tablet SR, even with pain relief, is inadvisable. Follow your physician's prescribed regimen. Abrupt cessation may trigger withdrawal effects including anxiety, insomnia, nausea, discomfort, and diaphoresis. A gradual reduction in Gblin M 750mcg/75mg Tablet SR dosage is recommended prior to complete discontinuation.
Taking Gblin M 750mcg/75mg Tablet SR may increase appetite, potentially leading to weight gain. Weight management is simpler than weight loss. Maintain a balanced diet without enlarging portions. Limit high-calorie foods like sugary drinks, fried foods, crisps, pastries, and confectionery. Between meals, choose fruits, vegetables, and low-calorie options instead of snacks. Regular physical activity aids in preventing weight gain. Consistent healthy eating and exercise may prevent any weight increase.
Gblin M 750mcg/75mg Tablet SR can induce drowsiness or sudden sleep onset during routine activities. This may occur without prior warning signs. Refrain from driving, operating equipment, working at heights, or engaging in hazardous tasks initially, until the medication's effects are known. Report any such incidents to your physician while using this medication.
While infrequent, Gblin M 750mcg/75mg Tablet SR can induce severe adverse reactions. These may include allergic responses, suicidal ideation, or limb edema (hands, feet, or legs). Discontinue Gblin M 750mcg/75mg Tablet SR and seek immediate medical attention if such effects appear. Allergic reactions manifest as facial, oral, lip, gum, tongue, or neck swelling; respiratory distress; skin rashes; urticaria (raised welts); or blisters. Monitor for abrupt shifts in mood, behavior, cognition, or affect, and report any suicidal thoughts.
Patients may observe initial improvements with Gblin M 750mcg/75mg Tablet SR within two weeks. Complete therapeutic effects, however, might require two to three months, or longer in certain individuals.
Should you miss a dose of Gblin M 750mcg/75mg Tablet SR, and your next dose is imminent, omit the missed dose and continue with your regular schedule. If, however, sufficient time remains before your next dose, take the missed dose immediately and then resume your usual medication regimen. Avoid doubling up on doses to compensate for a missed one, as this can heighten the likelihood of adverse reactions. For any uncertainty regarding missed doses, seek guidance from your physician.
Increasing the prescribed dosage won't necessarily improve results; in fact, it could heighten the risk of severe adverse reactions and harmful effects. If your symptoms worsen despite following the recommended dosage, seek medical advice for reassessment.
Refrain from consuming alcohol during Gblin M 750mcg/75mg Tablet SR treatment. Alcohol may worsen the drowsiness or sleepiness this medication produces.
Regular check-ups with your physician may be necessary following commencement of Gblin M 750mcg/75mg Tablet SR. Consult your doctor immediately if the prescribed dosage fails to alleviate your symptoms or if adverse reactions interfere with your daily life.
Protect your medication by leaving it in its original packaging until needed. Store the tablets in a cool, dry location, inaccessible to children. Proper disposal of any leftover medicine is crucial to prevent accidental ingestion by children, pets, or others.
Gblin M 750mcg/75mg Table...
113
MRP 138
18% off